MRNA Jan 2025 290.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
At close: 02:32PM EDT
| Previous Close | 0.6000 |
| Open | 0.4000 |
| Bid | 0.2500 |
| Ask | 0.4700 |
| Strike | 290.00 |
| Expire Date | 2025-01-17 |
| Day's Range | 0.4000 - 0.4700 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 264 |
Yahoo FinanceNovavax stock doubles after Sanofi deal marks 'new chapter' for company
Novavax stock popped Friday on news of a licensing deal and minority stake from Big Pharma player Sanofi.
Investor's Business DailyModerna Tumbles After The FDA Throws A Curveball On Its Second Product
Moderna stock toppled Friday after the FDA delayed an approval decision on its RSV vaccine until the end of the month.
Barrons.comFDA Delays Decision on Moderna RSV Shot by 3 Weeks
The agency was originally scheduled to announce its call on Sunday. The company said it hadn’t flagged any issues with the drug’s safety, efficacy, or quality.
© 2024 Yahoo. All rights reserved.